Evaluating the Economic and Operational Feasibility of Continuous Processes for Monoclonal Antibodies

First Author: Farid S
Attributed to:  EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/9783527673681.ch17

Publication URI: http://dx.doi.org/10.1002/9783527673681.ch17

Type: Book Chapter

Book Title: Continuous Processing in Pharmaceutical Manufacturing (2014)

Page Reference: 433-456